Related Experiment Videos
Long-term decrease of CD4+CD45RA+ T cells and impaired primary immune response after post-traumatic splenectomy
British Journal of Haematology
|October 16, 1999
Summary
Splenectomy, or spleen removal, impairs the immune system by reducing naive T cells (CD4+CD45RA+), affecting the body's ability to fight new infections. This long-term effect impacts primary immune responses.
Area of Science:
- Immunology
- Cellular immunology
Background:
- Absence of the spleen (splenectomy) or hyposplenism increases infection risk, particularly from encapsulated bacteria.
- The impact of splenectomy on cell-mediated immunity, especially regarding T cell subsets, remains largely uncharacterized.
Purpose of the Study:
- To investigate the long-term effects of splenectomy on peripheral blood lymphocyte subpopulations in humans.
- To assess the functional consequences of these changes on cell-mediated immunity, focusing on primary immune responses.
Main Methods:
- Analysis of peripheral blood lymphocyte subpopulations (CD4+ T cells, CD4+CD45RA+, CD4+CD45RO+) in splenectomized adults (>4 years post-surgery) and healthy controls.
- Assessment of lymphoproliferative responses and IFN-gamma production to recall antigens.
- Evaluation of T-cell proliferation to keyhole limpet haemocyanin and in vivo antibody responses to hepatitis A vaccine.
Main Results:
- A significant long-term reduction in CD4+ T cells, specifically the CD4+CD45RA+ (naive) subset, was observed in splenectomized individuals.
- Lymphoproliferative responses and IFN-gamma production to recall antigens were comparable between groups.
- Impaired primary immune responsiveness was evident, indicated by reduced T-cell proliferation to new antigens and diminished antibody responses post-vaccination.
Conclusions:
- The spleen may play a crucial role in the generation, maintenance, or differentiation of naive T cells or their precursors.
- Splenectomy can lead to a functional deficit in primary immune responses, potentially increasing susceptibility to novel pathogens.